[Other] Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial |
|
This post will be closed automatically in 2026-10-13 03:48
Reward10points
|
40
The Emergence of Artificial Intelligence: How Automation is Changing Auditing
20
An Introductory Guide to Skillful Therapist Positioning
20
Individual facial identification of beef and dairy cattle based on computer vision
10
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial
10
Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial
